What is the Summit?
A high-impact, invite-only gathering for healthcare leaders who want to make Precision Medicine a reality

Genetics offers enormous promise for human health, and for enabling transformative change in our healthcare system. However, the practical barriers to integrating genetics into clinical care delivery are undeniable. Because genetics is inherently data-intensive, critical challenges relate to the data and digital infrastructure that span across research, care delivery, and payment.

At the Genetic Health Information Network Summit, 100 top leaders from across healthcare, genetics, and technology gather to discuss critical improvements to the systems connecting genetic information in healthcare. The group, which includes CEOs, CMOs, CMIOs, Department Chairs, Research Directors, Managing Directors, Professors, Policymakers, and Patient Advocates, comes together for a candid, solution-oriented discussion on how to collectively overcome the barriers to achieving precision medicine at scale.

If this meeting sounds of interest to you, the organizers would be pleased to provide a 20-minute briefing about the meeting, format, and participant base to help you determine whether it’s a good match for your interests and goals.

If you would like to learn more, please complete the form. A meeting organizer will contact you to arrange a briefing.

Request a Briefing

Topics of Focus

For a sample of the topics covered at the Summit, download this whitepaper, which details the five core issues that emerged from the inaugural event:

  1. Genetic testing laboratory quality and patient safety;
  2. Clinical validity, utility, and value assessment at scale;
  3. Genetic test identification for market tracking, evidence-gathering, billing, and payment;
  4. Provider education, communication, and support at the point-of-care; and
  5. Patient access and control of genetic data.

Complete the form to download the paper.

Download the Paper

Past Organizers, Speakers & Authors

Titles and organizational affiliations may be reflective of the time of the event and may have since changed.

CARLOS BUSTAMANTE, PhD
Founder & CEO
Galatea Bio

GILLIAN HOOKER, PhD, ScM, CGC
Chief Scientific Officer
Concert Genetics

SUZANNE BELINSON, PhD, MPH
VP, Commercial Markets
Tempus

PRISCILLA ALFARO, MD
Chief Medical Officer
Zelis

STEVE GOLDBERG, MD
VP, Chief Health Officer, Medical Affairs & Diagnostic Services
Quest Diagnostics

VINCENT NELSON, MD
Senior Vice President, Medical Affairs
Centene

ROBERT NUSSBAUM, MD
Chief Medical Officer
Invitae

ANDY CORTS
SVP, Research & Analytics
SignalPath, a Verily company

BEN HO PARK, MD, PHD
Professor & Director, Division of Hematology and Oncology
Vanderbilt University Medical Center

ESTEBAN LÓPEZ
Chief Medical Officer, Clinical Strategy Innovation
HCSC (BCBS of IL, MT, NM, OK & TX)

SIMON BARNETT
Genomics Analyst
ARK Invest

DEE ANNA SMITH
CEO
Sarah Cannon

GEORGE CARDOZA
Senior Vice President, Chief Financial Officer
NeoGenomics

SEAN HOFHERR, PhD
Chief Scientific Officer
GeneDx, Inc.

JULIE M EGGINGTON, MS, PhD
Co-founder & CEO
Center for Genomic Interpretation

ERYNN GORDON, MS, LCGC
VP, Clinical Operations
Genome Medical

NIKOLETTA SIDIROPOULOS, MD
Medical Director, Genomic Medicine, Department of Pathology and Laboratory Medicine
University of Vermont Health Network

BAS VAN DER BAAN
Chief Clinical Officer
Agendia

PHILLIP FEBBO, MD
SVP & Chief Medical Officer
Illumina

HOWARD LEVY, MD, PhD
Associate Professor of Medicine
Johns Hopkins Medicine

KATE DONIGAN, PHD
Deputy Director, Personalized Medicine & Molecular Genetics (acting)
FDA

JILL HAGENKORD, MD
Chief Medical Officer
Optum Genomics

JIM JIRJIS, MD
Chief Health Information Officer
HCA Healthcare

BENJAMIN SOLOMON, MD
Clinical Director, National Human Genome Research Institute (NHGRI)
NIH

HOLLI DILKS, MD
Senior Director, Global Head of Field Medical
Foundation Medicine

ROBERT C. GREEN, MD, MPH
Director, Genomes2People
Division of Genetics at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School

JEFF EMCH
VP, Diagnostics Strategy, Global Oncology Marketing
GSK

NICOLE BOICE
Founder & CEO
Global Genes

DAVID MCCALLIE, MD
SVP, Medical Informatics
Cerner

EDWARD ABRAHAMS, PhD
President
Personalized Medicine Coalition

TAHA KASS-HOUT, MD
Former 1st Chief Health Informatics Officer
U.S. Food and Drug Administration (FDA)

GIL ALTEROVITZ, PhD
Director, Biomedical Cybernetics Laboratory
Harvard Medical School

KRISTINE BORDENAVE, MD
Corporate Medical Director
Humana

JOSHUA DENNY, MD
Professor of Biomedical Informatics and Medicine
Vanderbilt University

JAMES O’LEARY
Chief Innovation Officer
Genetic Alliance

HENRY GARLICH
Director, Healthcare Value Solutions & Enhanced Clinical Programs
Blue Shield of California

JIM ALMAS, MD
VP & National Medical Director for Clinical Effectiveness
LabCorp

MARA ASPINALL
Managing Director and Co-Founder
BlueStone Venture Partners

TRENT HAYWOOD, MD, JD
SVP & Chief Medical Officer
Blue Cross Blue Shield Association

STEPHANIE DEVANEY, PHD
Deputy Director, All of Us
NIH

EDMUND JACKSON, PHD
Chief Data Officer
HCA Healthcare

LISA ALDERSON
Co-founder & CEO
Genome Medical

DEBRA ESSER, MD
Chief Medical Officer
Blue Cross and Blue Shield of Nebraska

LAURIE MCGRAW
SVP, Health Solutions
American Medical Association

KATHRYN LANG, MD
Global Medical Strategy Head of Data Science
Pfizer

MATT MIGHT, PhD
Director, Hugh Kaul Personalized Medicine Institute
University of Alabama at Birmingham

VICTORIA PRATT, PhD
President
Association for Molecular Pathology

DAWN BARRY
Co-Founder and President
Luna DNA

ELI CASDIN
Chief Investment Officer
Casdin Capital

ELLEN MATLOFF, MS, CGC
President & CEO
My Gene Counsel

JULIE RAMAGE
National Accounts Director, Diagnostics
Pfizer

ALEX DE WINTER
Managing Director
GE Ventures

NICK NACLERIO, PhD
Founding Partner
Illumina Ventures

BRYCE OLSON
Global Marketing Director, Health and Life Sciences
Intel